Rick Pauls

Title: Rick Pauls: Innovator in Tissue Kallikrein Research

Introduction

Rick Pauls is a notable inventor based in Minnetonka, MN (US). He has made significant contributions to the field of biomedical research, particularly in the development of dosage forms for tissue kallikrein-1 polypeptides. With a total of 2 patents, his work has the potential to impact treatments for various medical conditions.

Latest Patents

Rick Pauls' latest patents focus on dosage forms of tissue kallikrein-1 (KLK1) polypeptides. These patents provide formulations that include a total KLK1 polypeptide dosage ranging from about 0.1 μg/kg to about 10.0 μg/kg. The dosage forms encompass both subcutaneous and intravenous applications. Additionally, the patents detail related devices and methods for treating ischemic and hemorrhagic conditions, showcasing the practical applications of his research.

Career Highlights

Rick Pauls has established himself as a key figure in the biomedical field through his innovative research and patent contributions. His work at Diamedica Inc. has allowed him to collaborate with other professionals and advance the understanding of tissue kallikrein-1's therapeutic potential.

Collaborations

Rick has worked alongside Todd Verdoorn, contributing to the collaborative efforts within Diamedica Inc. Their combined expertise enhances the research and development of new medical solutions.

Conclusion

Rick Pauls is a dedicated inventor whose work in tissue kallikrein research is paving the way for new treatment options. His patents reflect a commitment to advancing medical science and improving patient care.